# Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis Vaccines

> **NCT00004799** · PHASE3 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 10000 (—)

## Conditions studied

- Pertussis

## Interventions

- **BIOLOGICAL:** whole-cell pertussis vaccine
- **BIOLOGICAL:** diphtheria-tetanus vaccine

## Key facts

- **NCT ID:** NCT00004799
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1991-04
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 10000 (—)
- **Last updated:** 2005-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004799, "Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis Vaccines". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00004799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*